This article is more than 5 years old. Information may no longer be current.
MD Anderson names new vice provost
Click Here to Manage Email Alerts
George Wilding, MD, has been appointed vice provost for clinical and interdisciplinary research at The University of Texas MD Anderson Cancer Center.
Wilding also will serve as professor of genitourinary medical oncology. His appointment will take effect Sept. 1.
In his role as vice provost, Wilding will oversee strategic planning, conduct, approval and regulation of all clinical research conducted at MD Anderson and its global operations. He also will provide oversight and academic leadership for its multidisciplinary research institutes.
“I am confident that Dr. Wilding’s professional expertise and leadership experience have prepared him for this vital role,” Ethan Dmitrovsky, MD, provost and executive vice president at MD Anderson, said in a press release. “Additionally, his servant leadership approach and many other talents, including deep strategic thinking and thoughtfulness, will contribute substantially to our efforts to build upon our incredible foundation of critical clinical research advances.”
Wilding most recently served as professor of clinical oncology at University of Wisconsin School of Medicine and Public Health, as well as director emeritus of University of Wisconsin Carbone Cancer Center.